Taiwan develops microfluidic platform for rapid screening of diseases
Taiwan develops microfluidic platform for rapid screening of diseases Taiwan develops microfluidic platform for rapid screening of diseases 18 January 2021 | News Personalized Antibiotic Screening Platform fAST automates both genotype and phenotype detections to identify bacteria within 1.5 hours and finish the multiple antibiotics combination test within 5 hours Photo Credit: PRNewswire Taiwans Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrob...
Taiwan Health Rapid Detection Personalized Antibiotic Screening Platform Microfluidic Platform டைவாந் ஆரோக்கியம் விரைவான கண்டறிதல்
Source: biospectrumasia.com